How AI is Killing Biotech: The AbCellera Collapse Reveals a Brutal Truth (Part 1)
The Biotech Bloodbath of 2026 🩸 AbCellera (ABCL) has cratered 92.6% since its 2020 IPO. But this isn’t about one company’s missteps—it’s a canary in the coal mine. We’re witnessing the systematic dismantling of an entire sector. Here’s why most AI biotech companies won’t survive the next 18 months. The Great Disintermediation ⚡ Big Pharma Cuts Out the Middleman The pharmaceutical giants just rewrote the playbook: Old Model (2025): Big Pharma → AI Biotech → AI Platform New Model (2026): Big Pharma → AI Platform (Direct) ...